US approval of Teva drug could help reverse company's migraines

US approval of Teva drug could help reverse company's migraines

THE TEVA building in Jerusalem.. (photo credit: REUTERS) X Dear Reader, As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other […]

Bristol-Myers Squibb's New Psoriasis Drug Has Echoes of Humira

Bristol-Myers Squibb's New Psoriasis Drug Has Echoes of Humira

Could Bristol-Myers Squibb (NYSE:BMY) be the one to come out with the next Humira? Probably not, but its new drug candidate for plaque psoriasis BMS-986165 at least has a shot to come within the same ballpark. For shareholders, that may be enough. How did Humira get to be the best-selling drug of all time, and […]

OPP undecided on use of new roadside drug testing equipment as legalization looms

OPP undecided on use of new roadside drug testing equipment as legalization looms

The Ontario Provincial Police says it has not yet decided whether its officers will use federally approved roadside drug screening equipment to identify impaired drivers. The device, which received approval from the federal Department of Justice in August, is the Dräger DrugTest 5000, which tests saliva for cocaine and THC, the main psychoactive agent in cannabis. Each unit of the Dräger DrugTest 5000 comes with an “analyzer” […]

Pharma weekly wrap: FDC ban and Shivinder Singh's U-turn hog the limelight

Pharma weekly wrap: FDC ban and Shivinder Singh's U-turn hog the limelight

This was an action-packed week for the pharmaceutical and healthcare sectors with the ban on fixed drug combinations (FDCs), fresh developments in the Singh brothers’ saga and Sun Pharmaceutical Industries’ US Food and Drug Administration approval. FDC ban This week saw the government banning 329 Fixed Drug Combinations (FDCs). FDC is a cocktail of two or […]

US regulator approves Teva migraine drug, shares rise

US regulator approves Teva migraine drug, shares rise

Friday, September 14, 2018 5:28 p.m. CDT By Deena Beasley (Reuters) – Shares of Israeli drugmaker Teva Pharmaceutical Industries rose over 5 percent in after-hours trading on Friday after the U.S. Food and Drug Administration (FDA) approved the company’s new migraine treatment, a drug Teva has been banking on to help revive its fortunes. The […]

Dravet Syndrome Treatments

Dravet Syndrome Treatments

Supernus Pharmaceuticals (SUPN) dipped Friday as investors digested its $15 million plan to acquire a private biotech with an early-stage anti-epilepsy drug. X On the stock market today, Supernus stock sank 1.6%, to 48.05, after its announcement Thursday that it would buy Biscayne Neurotherapeutics. Shares initially dipped as much as 4.4%. Biscayne is developing a […]

US FDA nod to Sun Pharma's glaucoma drug

US FDA nod to Sun Pharma's glaucoma drug

The approval concerns Sun Pharma’s Halol (Gujarat) facility and negates recent concerns over the plant, the company said. Photo: Mint New Delhi: Sun Pharmaceutical Industries and its research arm Sun Pharma Advanced Research Company Ltd (SPARC) on Friday said it has got the US Food and Drug Administration’s (US FDA) approval for its new drug […]

Congress moves towards approval of massive anti-opioid bill

Congress moves towards approval of massive anti-opioid bill

ctmirror.org File Photo Sens. Chris Murphy and Richard Blumenthal. Washington – Congress is finally close to passing a comprehensive bill to combat opioid abuse, combining law enforcement and public health measures, including making addiction services more accessible. The U.S. House of Representatives approved legislation earlier this year aimed at combating opioid addiction, which has become […]

AZ nabs US approval for new leukaemia drug Lumoxiti

AZ nabs US approval for new leukaemia drug Lumoxiti

AstraZeneca has chalked up another product approval in its oncology franchise, getting an FDA nod for Lumoxiti, a new CD-22-targeted drug for rare cancer hairy cell leukaemia (HCL). Lumoxiti (moxetumomab pasudotox-tdfk) is the first new treatment for this type of leukaemia in 20 years, according to AZ. It has been approved for adults with relapsed […]

Roche's Child Arthritis Drug's New Formulation Gets FDA Nod

Roche's Child Arthritis Drug's New Formulation Gets FDA Nod

Roche Holding AG’s (RHHBY – Free Report) subsidiary, Genentech announced that the FDA has approved a label expansion for its arthritis drug, Actemra. The FDA approved a subcutaneous (SC) formulation — a prefilled syringe that can be injected at home —of Actemra for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in patients aged two […]